AMANDA SKAGGS: Open Payments
NPI 1275517229 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 23 payments from 9 companies in 2025. Trend: 2023 $209 · 2024 $172 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $100 |
| Astellas Pharma US Inc | 4 | $77 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $63 |
| Biogen, Inc. | 2 | $46 |
| Organon LLC | 3 | $38 |
| MILLICENT US INC | 1 | $17 |
| SANOFI PASTEUR INC. | 1 | $16 |
| Hologic Sales and Service, LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, GEMTESA, NEXPLANON, FEMLYV, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, THINPREP 2000 PROCESSOR.
Industry payments across MO — which companies pay providers there.
